ruthenium has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Hong, XJ; Li, WG; Ling, YY; Mao, ZW; Su, Q; Tan, CP; Wang, WJ; Wu, T; Zhang, CY; Zhou, JY | 1 |
| Biancalana, L; Mapanao, AK; Marchetti, F; Santi, M; Voliani, V | 1 |
2 other study(ies) available for ruthenium and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Ru(II)-modified TiO
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytokines; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunotherapy; Metal Nanoparticles; Mouth Neoplasms; Nanoparticles; Photosensitizing Agents; Rats; RNA, Small Interfering; Ruthenium; Squamous Cell Carcinoma of Head and Neck; Titanium; Tumor Microenvironment | 2022 |
Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomas.
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Ruthenium; Squamous Cell Carcinoma of Head and Neck; Structure-Activity Relationship | 2021 |